Skip to main content
. 2015 Jun 1;80(4):740–749. doi: 10.1111/bcp.12646

Table 5.

A,B. Outcomes

Treatment Time point n n Mean (SD)
A. Neonatal endpoints
Apgar score at 1 min Retosiban Birth 30 30 8.3 (0.88)
PBO Birth 34 34 8.2 (0.77)
Apgar score at 5 min Retosiban Birth 30 30 9 (0.53)
PBO Birth 34 34 8.9 (0.34)
Length (cm) Retosiban Birth 30 28 47.8 (2.78)
PBO Birth 34 34 47.8 (3.39)
Retosiban Follow-up 30 22 50.6 (2.89)
PBO Follow-up 34 29 51.3 (3.3)
Neonatal weight (g) Retosiban Birth 30 30 3099 (512.6)
PBO Birth 34 34 2940 (585.0)
Retosiban Follow-up 30 22 3427 (635.5)
PBO Follow-up 34 30 3602 (659.5)
Neonatal head circumference (cm) Retosiban Birth 30 27 33.3 (1.78)
PBO Birth 34 34 33.1 (1.63)
Retosiban Follow-up 30 21 35.1 (1.75)
PBO Follow-up 34 27 35.2 (1.77)
Time to follow-up (days) Retosiban Follow-up 30 22 18.4 (15.67)
PBO Follow-up 34 31 25.1 (20.45)
B. Gross development reported at follow-up
Treatment n Normal Abnormal Not reported
Gross development Retosiban 30 22 0 8
PBO 34 30 1 3